Source: Eur Respir Monogr 2015; 69: 47-84
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Damian Bruce-Hickman, Catherine M. Greene, Bibek Gooptu. a₁-antitrypsin deficiency. Eur Respir Monogr 2015; 69: 47-84

Member's Comments

No comment yet.

Related content which might interest you: Bronchiectasis in alpha1-antitrypsin deficiency Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Update on a1-antitrypsin deficiency Source: Breathe, 14 (2) e17; 10.1183/20734735.015018 Year: 2018 What we have learned about alpha-1-antitrypsin deficiency Source: Virtual Congress 2021 – Rare lung diseases 2021 Year: 2021 Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Pulmonary administration of alpha1-antitrypsin for the treatment of Alpha1-antitrypsin deficiency Source: Eur Respir J 2003; 22: Suppl. 45, 385s Year: 2003 Alpha-1-antitrypsin deficiency Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139 Year: 2005 Plasma protein profiling in alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Vitamin D deficiency and activity of sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Rare SERPINA1 allele Mwhitstable in patients with Alpha1-antitrypsin deficiency Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Effect of danazol on acute phase reactants in patients with PiM, PiMZ and PiZ phenotypes for alpha-1-antitrypsin deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Diagnosis and management of alpha1-antitrypsin deficiency Source: Breathe 2007; 4: 38-46 Year: 2007 Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Family screening in alpha1-antitrypsin deficiency Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Occupational exposure in alpha-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD and other environment-related lung diseases Year: 2008 Mortality of patients with emphysema and alpha-1-antitrypsin deficiency of Pi Z phenotype Source: Eur Respir J 2001; 18: Suppl. 33, 25s Year: 2001